Boult Wade Tennant
Bulletins » EPO Notice regarding the 10 day rule

The EPO have published further information in a Notice in the Official Journal dated 6 March 2023 in preparation for the abolition of the 10 day rule (found here: EPO – Notice from the European Patent Office dated 6 March 2023 concerning amended Rules 126, 127 and 131 EPC). In particular, the Notice provides clarification regarding the amendments that are being made to Rules 126(2), 127(2) and 131(2) EPC, which currently give rise to the 10 day rule. These amendments are due to enter into force on 1 November 2023 and will strengthen the alignment of the EPO’s approach with that of the PCT.

As it stands, notifications from the EPO are deemed to have been delivered to the addressee on the tenth day following the date of the document to account for postal delays. When the changes come into force, the date upon which notification is deemed to have occurred will be the date shown on the document and deadlines will be calculated from this date, thereby ending the allowance of an additional 10 days.

The Notice also provides helpful updates in relation to transitional provisions. The EPO have confirmed that since it is the issuing of a document that triggers the notification process, the date of that document will be used to determine whether the new rules apply. Therefore, for any document which is dated 1 November 2023 or later, the new rules will apply and the document will be deemed delivered on the date is bears. If the date on the document is earlier than 1 November 2023, the 10 day notification fiction will remain applicable and the document will be deemed delivered on the tenth day, with any deadlines calculated therefrom (even if the deadline is 1 November 2023 or later). Accordingly, for those who docket the additional days upon notification, there is no need to change practice over the next six months until 1 November 2023.

The EPO Notice provides a few illustrative examples. One such example considers a document bearing a date of 31 October 2023 which is issued on this date and delivered to the addressee by postal services on 2 November 2023. Since the date of this document lies before 1 November 2023, it will be deemed notified on the tenth day following its dispatch, i.e. on 10 November 2023. This date will be used for the purpose of any time-limit calculation under Rule 131(2) EPC. For example, if the document triggers a two month deadline, this will expire 10 January 2024. On the other hand, another example in the Notice considers a document bearing a date of 2 November 2023 which is issued on this date and delivered to the addressee by postal services on 3 November 2023. Since the date of this document lies after 1 November 2023, the amended rules will apply and the document will be deemed notified on 2 November 2023. In this case, if the document triggers a two month deadline, this will expire 2 January 2024.

Safeguards will remain in place where a document is not received and the EPO is unable to prove that a document had been delivered. In this case, the document will be reissued with a new date. Where a document has been delivered late, the EPO will adopt similar provisions to the PCT. In particular, if notification is contested and the EPO is unable to prove that a document was delivered within seven days of the date it bears, any deadline calculated from the notification date will be extended by the number of days the document was received later than seven days after the date of the document. For instance, if the addressee received the document twelve days after the date it bears, the period will be extended by five days under the safeguard.

If you have any questions, please do not hesitate to contact your usual Boult Wade Tennant adviser.

Relevant sectors
Aerospace
  • Commercial aviation
  • Defence and security
  • Space and satellites
  • Unmanned aerial vehicles
Artificial Intelligence and Machine Learning
Automotive
  • Autonomous vehicles
  • Electric vehicles
  • Engines
Biotechnology
  • Antibody engineering
  • Antibody manufacture and formulation
  • Bioinformatics
  • Biosimilars
  • Drug delivery
  • Gene editing (e.g. CRISPR)
  • Genomic and molecular tools and methods
  • GM crops
  • Immuno-oncology (e.g. checkpoint inhibitors; modified T cells)
  • Next generation sequencing
  • Nucleic acid synthesis
  • Personalised medicine/disease biomarkers
  • Recombinant protein production and purification
  • Stem cell therapies
  • Supplementary protection certificates (SPCs)
  • Synthetic biology
  • Therapeutic antibodies
  • Vaccinology (e.g. viral vectors; mRNA vaccines)
  • Women’s health products
Chemicals
  • Agrochemicals
  • Catalysts
  • Dispersions and colloids
  • Lubricants
  • Polymers and plastics
Communications and Networks
  • Cloud computing
  • Internet of things (IOT)
  • Oceanography, marine
  • Wired and wireless networks
Computing and Software
  • Artificial intelligence and machine learning
  • Bioinformatics
  • Blockchain and distributed ledgers
  • Communications and networks
  • Computer games
  • Data and software security, cryptography and digital rights management (DRM)
  • Data management and storage, databases and data compression
  • Digital assistants, virtual assistants and software agents
  • Fintech and adtech
  • Machine vision
  • Metaverse, virtual reality (VR) and augmented reality (AR)
  • Motor capture
  • Multimedia, audio/video processing and animation
  • Natural language processing
  • Quantum computing
  • Robotic process automation
  • Search engines
  • Signal processing
  • Software applications and systems, mobile applications, user interfaces
Consumer Goods and Retail
  • Anti-counterfeit devices
  • Beauty
  • Fashion
  • Health, fitness and sport
  • Household goods
  • Luxury goods
  • Moda
  • Retail
Electronics and Electrical Devices
  • Computer and IT architecture and system design
  • Medical devices
  • Optics
  • Restaurants and bars
  • Robotics
  • Scientific instruments
  • Semiconductor devices
  • Testing systems, control systems, signal processing
  • Travel and leisure
  • Wearable tech and human interfaces
Energy and Green Technologies
  • Biofuels
  • Clean air
  • Fuel cells and battery technology
  • Renewables and recycling
  • Solar power
  • Water, oil and gas, nuclear, fusion, fission
  • Wind turbines
Food and Beverage
  • Beverages
  • Nutrition
  • Retail
Industrial Manufacturing and Processing
  • Packaging
  • Polymers and plastics
  • Printing tech
  • Additive manufacturing
  • Coatings
  • Construction
Materials
  • Advanced materials
  • Composite materials
  • Metallurgy and alloys
  • Nanotechnology
Medical Devices and Diagnostics
  • Artificial intelligence
  • Devices
  • Diagnostic instruments
  • Digital health
  • Drug delivery
  • Immuno-oncology
  • In vitro diagnostics
  • Medtech
Pharmaceuticals
  • Diagnostics
  • Drug delivery
  • Generic market entry
  • Medicinal chemistry
  • Methods of production and synthesis
  • Personalised medicine/disease biomarkers
  • Pharmaceutical formulations
  • Pharmaceuticalsceutical formulations
  • Polymorphs
  • Small molecule pharmaceuticals
  • Supplementary protection certificates (SPCs)
Trade Marks
  • Consumer goods
  • Cosmetics and perfumery
  • Financial services
  • Mechanical engineering
  • Mechanical products
  • Services
  • Telecommunications
Relevant sectors